Pfizer has abandoned work on a PD-L1-targeting drug that was being tested in patients with various cancers. | Pfizer has ...
CORRECTION: This article has been updated to correct the comparable weight loss and discontinuation rate for the Wegovy pill. Shares of Structure Therapeutics rallied 5.4% on Monday after the company ...
This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...
A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based ...
AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Biotech and health care exchange-traded funds let you invest in dozens or even hundreds of companies working on groundbreaking treatments, therapies and vaccines. Many, or all, of the products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results